Volume 11 Supplement 1

Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection

Open Access

Age-related co-morbidities in people living with HIV

  • G Guaraldi1,
  • S Zona1,
  • G Orlando1,
  • N Squillace1,
  • C Stentarelli1,
  • G Nardini1,
  • B Beghetto1,
  • R Esposito1 and
  • FJ Palella2
Journal of the International AIDS Society200811(Suppl 1):P300

https://doi.org/10.1186/1758-2652-11-S1-P300

Published: 10 November 2008

Purpose of the study

To describe prevalence of age-related morbidities across age groups in people living with HIV/AIDS and analyze care needs in the elderly people.

Methods

Consecutive patients attending a metabolic clinic. Body fat changes, metabolic, cardiovascular, endocrine and renal morbidities were identified as relevant medical conditions requiring drug intervention (either switch of ARVs or introduction of specific drug classes).

Summary of results

ANOVA was used for means and chi-square test for proportions except:

* Kruskal-Wallis

* Fisher's exact

Prevalence of three or more co-morbidities in the age group were: 7.89% for age ≤30, 24.68% for age 30–40, 33.72% for age 40–50, 49.01% for age 50–60 and 60.87% for age >60 years. (Figure 1.)

Conclusion

Metabolic, cardiovascular, endocrine, hepatic and kidney disease are age-associated conditions highly prevalent in people living with HIV. Multiple co-morbidities increase with age and witness the multidisciplinary care needs of the HIV aging population.

Figure 1

Authors’ Affiliations

(1)
University of Modena and Reggio Emilia
(2)
Northwestern University, Feinberg School of Medicine

Copyright

© Guaraldi et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.

Advertisement